BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35773446)

  • 1. Recent Developments in Ionic Liquid-Assisted Topical and Transdermal Drug Delivery.
    Ali MK; Moshikur RM; Goto M; Moniruzzaman M
    Pharm Res; 2022 Oct; 39(10):2335-2351. PubMed ID: 35773446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of Hydrophilic Drug into Oil-Miscible Ionic Liquids for Transdermal Drug Delivery.
    Md Moshikur R; Shimul IM; Uddin S; Wakabayashi R; Moniruzzaman M; Goto M
    ACS Appl Mater Interfaces; 2022 Dec; 14(50):55332-55341. PubMed ID: 36508194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design Principles of Ionic Liquids for Transdermal Drug Delivery.
    Tanner EEL; Curreri AM; Balkaran JPR; Selig-Wober NC; Yang AB; Kendig C; Fluhr MP; Kim N; Mitragotri S
    Adv Mater; 2019 Jul; 31(27):e1901103. PubMed ID: 31112631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal Delivery of Metformin Utilizing Ionic Liquid Technology: Insight Into the Relationship Between Counterion Structures and Properties.
    Hong M; Wang Q; Wang K; Li J; Qi MH; Ren GB
    Pharm Res; 2022 Oct; 39(10):2459-2474. PubMed ID: 36171345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Applications of Ionic Liquids: A Personal Account.
    Md Moshikur R; Goto M
    Chem Rec; 2023 Aug; 23(8):e202300026. PubMed ID: 37042429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatible Ionic Liquid Enhances Transdermal Antigen Peptide Delivery and Preventive Vaccination Effect.
    Tahara Y; Morita K; Wakabayashi R; Kamiya N; Goto M
    Mol Pharm; 2020 Oct; 17(10):3845-3856. PubMed ID: 32902989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluations of imidazolium ionic liquids as novel skin permeation enhancers for drug transdermal delivery.
    Zhang D; Wang HJ; Cui XM; Wang CX
    Pharm Dev Technol; 2017 Jun; 22(4):511-520. PubMed ID: 26763663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionic liquid-based transdermal delivery of propranolol: a patent evaluation of US2018/0169033A1.
    Chopra H; Kumar P; Singh I
    Pharm Pat Anal; 2019 Sep; 8(5):203-209. PubMed ID: 31612799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of choline-based ionic liquids in drug delivery.
    Li X; Ma N; Zhang L; Ling G; Zhang P
    Int J Pharm; 2022 Jan; 612():121366. PubMed ID: 34896216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionic liquids as potential enhancers for transdermal drug delivery.
    Monti D; Egiziano E; Burgalassi S; Chetoni P; Chiappe C; Sanzone A; Tampucci S
    Int J Pharm; 2017 Jan; 516(1-2):45-51. PubMed ID: 27836753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and cytotoxicity evaluation of biocompatible amino acid esters used to convert salicylic acid into ionic liquids.
    Moshikur RM; Chowdhury MR; Wakabayashi R; Tahara Y; Moniruzzaman M; Goto M
    Int J Pharm; 2018 Jul; 546(1-2):31-38. PubMed ID: 29751143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionic liquid - microemulsions assisting in the transdermal delivery of Dencichine: Preparation, in-vitro and in-vivo evaluations, and investigation of the permeation mechanism.
    Wang C; Zhu J; Zhang D; Yang Y; Zheng L; Qu Y; Yang X; Cui X
    Int J Pharm; 2018 Jan; 535(1-2):120-131. PubMed ID: 29104058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Transdermal Delivery System for Diabetes Treatment Using a Biocompatible Ionic Liquid-Based Microemulsion.
    Islam MR; Uddin S; Chowdhury MR; Wakabayashi R; Moniruzzaman M; Goto M
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):42461-42472. PubMed ID: 34460218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline and amino acid based biocompatible ionic liquid mediated transdermal delivery of the sparingly soluble drug acyclovir.
    Islam MR; Chowdhury MR; Wakabayashi R; Tahara Y; Kamiya N; Moniruzzaman M; Goto M
    Int J Pharm; 2020 May; 582():119335. PubMed ID: 32311469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionic liquids as ingredients in topical drug delivery systems.
    Dobler D; Schmidts T; Klingenhöfer I; Runkel F
    Int J Pharm; 2013 Jan; 441(1-2):620-7. PubMed ID: 23123180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline- versus imidazole-based ionic liquids as functional ingredients in topical delivery systems: cytotoxicity, solubility, and skin permeation studies.
    Santos de Almeida T; Júlio A; Saraiva N; Fernandes AS; Araújo MEM; Baby AR; Rosado C; Mota JP
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1858-1865. PubMed ID: 28665154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel skin permeation enhancers based on amino acid ester ionic liquid: Design and permeation mechanism.
    Zheng L; Zhao Z; Yang Y; Li Y; Wang C
    Int J Pharm; 2020 Feb; 576():119031. PubMed ID: 31953082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular design of drug-ionic liquids for transdermal drug delivery: Mechanistic study of counterions structure on complex formation and skin permeation.
    Yang D; Liu C; Ding D; Quan P; Fang L
    Int J Pharm; 2021 Jun; 602():120560. PubMed ID: 33798684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal insulin delivery using choline-based ionic liquids (CAGE).
    Tanner EEL; Ibsen KN; Mitragotri S
    J Control Release; 2018 Sep; 286():137-144. PubMed ID: 30026081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid.
    Miwa Y; Hamamoto H; Ishida T
    Eur J Pharm Biopharm; 2016 May; 102():92-100. PubMed ID: 26945484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.